Monday, September 18, 2006

Strapharma Holdings Retains Cronus Capital Markets to Build Market


Strapharma Holdings Retains Cronus Capital Markets to Build Market
dBusinessNews New York (press release), NY - Sep 12, 2006 s lead development product is VivaGel (SPL7013Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.

Herpes